WHO ICTRP trial

Phase I Clinical Study for 3D Stem Cell Microspheres Therapy for Patients with…

ChiCTR1900021535 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR1900021535
Public title Phase I Clinical Study for 3D Stem Cell Microspheres Therapy for Patients with Advanced Lung Cancer
Scientific title Phase I Clinical Study for 3D Stem Cell Microspheres Therapy for Patients with Advanced Lung Cancer
Primary sponsor West China Hospital, Sichuan University
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Observational study
Phase 1
Countries China
Conditions Lung Cancer
Interventions Stem cell low dose group:Subcutaneous inject X-ray irradiated umbilical cord adult stem cell 3D microsphere;Stem cell medium dose group:Subcutaneous inject X-ray irradiated umbilical cord adult stem cell 3D microsphere;Stem cell high dose…
Registration date Feb 26, 2019
Target size Stem cell low dose group:6;Stem cell medium dose group:6;Stem cell high dose…
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations